The asymmetric unit of the title crystal structure is shown in the gure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.
(10 mmol), 4-bromobenzaldehyde (10 mmol), malononitrile (10 mmol) and 4-(dimethylamino)pyridine (DMAP) (1 mmol) in ethanol (100 mL) was re uxed for 2-3 h and then cooled to room temperature. After ltering the precipitates, they were sequentially washed with ice-cooled water and ethanol and then dried under vacuum.
Experimental details
The H atoms bonded to C and N were positioned geometrically and re ned using a riding model, with C-H = 0.93 Å and 0.86 Å and with U iso (H) = 1.2Ueq(C,N).
Discussion
The synthesis of pyrans and their derivatives has attracted considerable attention from organic and medicinal chemists for many years as a large number of natural and synthetic products contain this heterocyclic nucleus [1, 2] . Pyrans possess diverse pharmacological and biological activities such as antitumor, analgesic and ulcerogenic, antiin ammatory, anticoagulant, phototriggering, and fungicidal properties, and can act as anticoagulants in the production of pesticides [3, 4] . In particular, the anticancer activity of pyran compounds has received considerable attention because of their cytotoxic activity against numerous types of cancers, including malignant melanoma, leukemia, renal cell carcinoma, prostate and breast cancer cell progression [5] .
In the crystal structure of the title compound, the 4H-pyran ring is nearly planar and the adjacent pyran-2-on-3,4-diyl ring also adopts an almost planar conformation. The 
